Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sharon Muzerengi"'
Autor:
Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj, Jing Ming Yeo, Liqun Zhang, Ghaniah Hassan-Smith, Matthew Jones, Christopher Hutchcroft, Esther Hobson, Dana Warcel, Daniel White, Phillip Ferdinand, Alastair Webb, Tom Solomon, Marie Scully, David J Werring, Christine Roffe, Sara Al-izzi, Aravindhan Baheerathan, Soma Banerjee, Gary Benson, Claudia Boshier, Sandeep Buddha, Nathan Burley, Ruaridh Cameron Smail, Arvind Chandratheva, Pavel Chudakou, Philip Clatworthy, Alasdair Coles, Thomas Cox, Ranjit Dasgupta, Richard Davenport, Darrell Devine, Stephen Fenlon, Carolyn Gabriel, Rita Ghatala, Claire Hall, Milan Hargovan, Kirsty Harkness, Ian Harvey, Lucy Hicken, Laura Howaniec, Abubaker Ibnouf, Luis Idrovo, Gordon Ingle, Yong Kyan Lee, Ailidh Lang, Simon McBride, Malcolm McLeod, Ruth Medlock, Puja Mehta, Ian Morrison, Girish Muddegowda, Sharon Muzerengi, Donald Pang, Gopinath Periyasamy, Gavin Preston, Naomi Priestley, Lydia Revicka, Sadia Saber, Elliott Smith, Youssef Sorour, Oliver Spooner, Jon Stone, Laszlo Sztriha, Narmathey Thambirajah, Rhys Thomas, David Veale, Jasmine Wall, Sarah White, James White, Syarah Yusoff, Laura Zambreanu
Publikováno v:
Lancet (London, England)
LANCET
LANCET
Background: A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous thrombosis is the most common manifestation of this syndrome but, to our knowle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd9fef3e16362f6577bc8d3cd07ae55
https://www.repository.cam.ac.uk/handle/1810/327808
https://www.repository.cam.ac.uk/handle/1810/327808
Autor:
Caroline Rick, Carl E Clarke, Natalie Ives, Rebecca Woolley, I. Begaj, Sharon Muzerengi, Felicity Evison
Publikováno v:
Public Health. 146:4-9
Objectives Hospital Episode Statistics data are used for healthcare planning and hospital reimbursements. Reliability of these data is dependent on the accuracy of individual hospitals reporting Secondary Uses Service (SUS) which includes hospitalisa
Autor:
Carl‐Christian Moor, Sharon Muzerengi
Publikováno v:
Progress in Neurology and Psychiatry. 17:20-24
There is a high prevalence of depression in epilepsy; however, this comorbidity remains under-recognised and undertreated. Here, Dr Muzerengi and Dr Moor discuss the characteristics, assessment and management of depression in people with epilepsy.
Autor:
Carl E Clarke, Sharon Muzerengi
Publikováno v:
BMJ (Clinical research ed.). 351
In answer to Braithwaite, our recommendations were based on the National Institute for Health and Care Excellence (NICE) guidance on management of depression.1 2 3 We agree that reboxetine is not an effective treatment, as …
Publikováno v:
Prescriber. 19:56-59
Restless legs is a common condition characterised by abnormal involuntary movements of the legs, often occurring during sleep. Here the authors describe its features and treatment. Copyright © 2008 Wiley Interface Ltd
Publikováno v:
Parkinsonism & Related Disorders. 13:S450-S456
Non-motor symptoms are an important part of Parkinson's disease (PD) symptoms complex. They cause a significant burden on the quality of life of patients and their carers and remain a major cause of hospitalisation. Treatment of non-motor symptoms ca
Publikováno v:
Prescriber. 18:19-30
Rotigotine (Neupro) is the first dopamine agonist skin patch to become available. Our New products review considers the clinical-trial evidence for its efficacy and tolerability in the treatment of early and advanced Parkinson's disease. Copyright ©
Publikováno v:
Parkinsonismrelated disorders. 24
The neurodegenerative process in Parkinson's disease (PD) results in a relentless progression of motor and non-motor symptoms. Affected individuals are frequently hospitalised for complications of the disease including falls, fractures, infections, a
Autor:
Sharon Muzerengi, K. Ray Chaudhuri, P Martinez-Martin, Helen Lewis, Martk Edwards, Anuj Bahl, Emma Kipps
Publikováno v:
Aging Health. 2:967-982
Parkinson's disease results from degeneration of the substantia nigra pars compacta and the consequent dysfunction of the dopaminergic nigrostriatal pathway. Serotonergic and noradrenergic pathways are also affected. However, It has been recognized t
Autor:
Sharon Muzerengi, K. Ray Chaudhuri
Publikováno v:
Scopus-Elsevier